Table 1.
Clinical Features | hsa_circ_0013520 Expression | P-value | hsa_circ_0004379 Expression | |||
---|---|---|---|---|---|---|
Low | High | Low | High | P-value | ||
Gender | 0.747 | 0.799 | ||||
Male | 30 | 19 | 27 | 22 | ||
Female | 22 | 21 | 23 | 20 | ||
Age (years) | 0.511 | 0.641 | ||||
<50 | 31 | 24 | 29 | 23 | ||
≥50 | 21 | 16 | 23 | 19 | ||
KPS | 0.008 | 0.006 | ||||
< 90 | 33 | 37 | 32 | 39 | ||
≥ 90 | 19 | 3 | 18 | 3 | ||
TNM stage | 0.004 | 0.005 | ||||
I–II | 12 | 2 | 14 | 3 | ||
>III | 40 | 38 | 36 | 39 | ||
Tumor size | < 0.001 | <0.001 | ||||
≤3 cm | 4 | 1 | 5 | 2 | ||
≥3 cm | 48 | 39 | 45 | 40 |
Abbreviation: KPS, Karnofsky Performance Status.